Elevated Levels of Endocannabinoids in Chronic Hepatitis C May Modulate Cellular Immune Response and Hepatic Stellate Cell Activation

Endocannabinoid system activation contributes to glucose metabolism disorders of hepatocytes and promotes hepatitis C virus replication

(2014) Li-Jie Sun et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Endocannabinoid CB1 antagonists inhibit hepatitis C virus production, providing a novel class of antiviral host-targeting agents

(2014) M. Shahidi et al.   JOURNAL OF GENERAL VIROLOGY

Metabolomic tissue signature in human non-alcoholic fatty liver disease identifies protective candidate metabolites

(2014) Witigo von Schönfels et al.   LIVER INTERNATIONAL

Monoacylglycerol Lipase Controls Endocannabinoid and Eicosanoid Signaling and Hepatic Injury in Mice

(2013) Zongxian Cao et al.   GASTROENTEROLOGY

Cannabinoid receptor 2 counteracts interleukin-17-induced immune and fibrogenic responses in mouse liver

(2013) Adrien Guillot et al.   HEPATOLOGY

Cannabinoid signaling and liver therapeutics

(2013) Ariane Mallat et al.   JOURNAL OF HEPATOLOGY

Impaired CD4+ T cell stimulation of NK cell anti-fibrotic activity may contribute to accelerated liver fibrosis progression in HIV/HCV patients

(2013) Andreas Glässner et al.   JOURNAL OF HEPATOLOGY

The endocannabinoid system in advanced liver cirrhosis: pathophysiological implication and future perspectives

(2013) Maurizio Baldassarre et al.   LIVER INTERNATIONAL

Plasma Concentrations of Endocannabinoids and Related Primary Fatty Acid Amides in Patients with Post-Traumatic Stress Disorder

(2013) Daniela Hauer et al.   PLoS One

Time-dependent effect of in vivo inflammation on eicosanoid and endocannabinoid levels in plasma, liver, ileum and adipose tissue in C57BL/6 mice fed a fish-oil diet

(2012) Michiel G.J. Balvers et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Evidence for Bidirectional Endocannabinoid Transport across Cell Membranes

(2012) Andrea Chicca et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Serum Metabolic Profiling Study of Hepatocellular Carcinoma Infected with Hepatitis B or Hepatitis C Virus by Using Liquid Chromatography–Mass Spectrometry

(2012) Lina Zhou et al.   JOURNAL OF PROTEOME RESEARCH

The endocannabinoid system as a key mediator during liver diseases: new insights and therapeutic openings

(2011) A Mallat et al.   BRITISH JOURNAL OF PHARMACOLOGY

Cannabinoid CB2 receptors protect against alcoholic liver disease by regulating Kupffer cell polarization in mice

(2011) Alexandre Louvet et al.   HEPATOLOGY

Altered hepatic lipid metabolism in C57BL/6 mice fed alcohol: a targeted lipidomic and gene expression study

(2011) Robin D. Clugston et al.   JOURNAL OF LIPID RESEARCH

Unknown

(2011) Eleonora Patsenker et al.   MOLECULAR MEDICINE

Virus-specific CD4+ T cell responses in chronic HCV infection in blood and liver identified by antigen-specific upregulation of CD154

(2010) Mareike Mueller et al.   JOURNAL OF HEPATOLOGY

Anandamide Suppresses Proliferation and Cytokine Release from Primary Human T-Lymphocytes Mainly via CB2 Receptors

(2010) Maria Teresa Cencioni et al.   PLoS One

Hepatitis C Virus Induces the Cannabinoid Receptor 1

(2010) David van der Poorten et al.   PLoS One

Cannabinoids as novel anti-inflammatory drugs

(2009) Prakash Nagarkatti et al.   Future Medicinal Chemistry

Circulating and hepatic endocannabinoids and endocannabinoid-related molecules in patients with cirrhosis

(2009) Paolo Caraceni et al.   LIVER INTERNATIONAL

Endocannabinoids and Liver Disease. III. Endocannabinoid effects on immune cells: implications for inflammatory liver diseases

(2008) Pál Pacher et al.   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

Influence of Cannabis Use on Severity of Hepatitis C Disease

(2008) Julie H. Ishida et al.   Clinical Gastroenterology and Hepatology

Inhibition of Integrin αvβ6 on Cholangiocytes Blocks Transforming Growth Factor-β Activation and Retards Biliary Fibrosis Progression

(2008) Eleonora Patsenker et al.   GASTROENTEROLOGY

Attenuation of Experimental Autoimmune Hepatitis by Exogenous and Endogenous Cannabinoids: Involvement of Regulatory T Cells

(2008) V. L. Hegde et al.   MOLECULAR PHARMACOLOGY

Targeting the endocannabinoid system: to enhance or reduce?

(2008) Vincenzo Di Marzo   NATURE REVIEWS DRUG DISCOVERY

Role of cannabinoids in chronic liver diseases

(2008) Anna Parfieniuk et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Endocannabinoids and Liver Disease. II. Endocannabinoids in the pathogenesis and treatment of liver fibrosis

(2007) Sören V. Siegmund et al.   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

Daily Cannabis Use: A Novel Risk Factor of Steatosis Severity in Patients With Chronic Hepatitis C

(2007) Christophe Hézode et al.   GASTROENTEROLOGY